Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 11 results.
User Information
Export Records
  1. 1.   CDK2 inhibition disorders centrosome stoichiometry and alters cellular outcomes in aneuploid cancer cells
  2. Chen,Zibo; Liu,Xi; Kawakami, Masanori; Liu,Xiuxia; Baker, Allison; Bhatawadekar, Aayush; Tyutyunyk-Massey,Liliya; Narayan,Kedar; Dmitrovsky,Ethan
  3. Cancer Biology & Therapy. 2023, Dec 31; 24(1): 2279241.
  1. 2.   Speedy A-Cdk2 binding mediates initial telomere-nuclear envelope attachment during meiotic prophase I independent of Cdk2 activation.
  2. Tu, Zhaowei; Bayazit, Mustafa Bilal; Liu, Hongbin; Zhang, Jingjing; Busayavalasa, Kiran; Risal, Sanjiv; Shao, Jingchen; Satyanarayana, Ande; Coppola, Vincenzo; Tessarollo, Lino; Singh, Meenakshi; Zheng, Chunwei; Han, Chunsheng; Chen, Zijiang; Kaldis, Philipp; Gustafsson, Jan-Åke; Liu, Kui
  3. Proceedings of the National Academy of Sciences of the United States of America. 2017, Jan 17; 114(3): 592-597.
  1. 3.   Cdk2 plays a critical role in hepatocyte cell cycle progression and survival in the setting of cyclin D1 expression in vivo
  2. Hanse, E. A.; Nelsen, C. J.; Goggin, M. M.; Anttila, C. K.; Mullany, L. K.; Berthet, C.; Kaldis, P.; Crary, G. S.; Kuriyama, R.; Albrecht, J. H.
  3. Cell Cycle. 2009 8(17): 2802-2809.
  1. 4.   Kinase-independent function of cyclin E
  2. Geng, Y.; Lee, Y. M.; Welcker, M.; Swanger, J.; Zagozdzon, A.; Winer, J. D.; Roberts, J. M.; Kaldis, P.; Clurman, B. E.; Sicinski, P.
  3. Molecular Cell. 2007, Jan; 25(1): 127-139.
  1. 5.   CDK2 is required by MYC to induce apoptosis
  2. Deb-Basu, D.; Aleem, E.; Kaldis, P.; Felsher, D. W.
  3. Cell Cycle. 2006, Jun; 5(12): 1342-1347.
  1. 6.   Combined loss of Cdk2 and Cdk4 results in embryonic lethality and Rb hypophosphorylation
  2. Berthet, C.; Klarmann, K. D.; Hilton, M. B.; Suh, H. C.; Keller, J. R.; Kiyokawa, H.; Kaldis, P.
  3. Developmental Cell. 2006, MAY; 10(5): 563-573.
  1. 7.   Cell cycle sibling rivalry - Cdc2 vs. Cdk2
  2. Kaldis, P.; Aleem, E.
  3. Cell Cycle. 2005, NOV; 4(11): 1491-1494.
  1. 8.   Homology model of the CDK1/cyclin B complex
  2. McGrath, C. F.; Pattabiraman, N.; Kellogg, G. E.; Lemcke, T.; Kunick, C.; Sausville, E. A.; Zaharevitz, D. W.; Gussio, R.
  3. Journal of Biomolecular Structure & Dynamics. 2005, APR; 22(5): 493-502.
  1. 9.   Effect of cell cycle inhibition on cisplatin-induced cytotoxicity
  2. Fishel, M. L.; Newell, D. R.; Griffin, R. J.; Davison, R.; Wang, L. Z.; Curtin, N. J.; Zuhowski, E. G.; Kasza, K.; Egorin, M. J.; Moschel, R. C.; Dolan, M. E.
  3. Journal of Pharmacology and Experimental Therapeutics. 2005, JAN; 312(1): 206-213.
  1. 10.   Structure-based design modifications of the paullone molecular scaffold for cyclin-dependent kinase inhibition
  2. Gussio, R.; Zaharevitz, D. W.; McGrath, C. F.; Pattabiraman, N.; Kellogg, G. E.; Schultz, C.; Link, A.; Kunick, C.; Leost, M.; Meijer, L.; Sausville, E. A.
  3. Anti-Cancer Drug Design. 2000 15(1): 53-66.
  1. 11.   Association of Cdk2/Cyclin E and Nf-Kappa-B Complexes At G1/S Phase
  2. Chen, E. Y.; Li, C. C. H.
  3. Biochemical and Biophysical Research Communications. 1998 249(3): 728-734.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel